15 results on '"Lage Y"'
Search Results
2. P4.11E.23 Real-World Data (RWD) Of First-Line Cemiplimab Single Agent for Advanced PD-L1 High Expression, Non-Small Cell Lung Cancer (NSCLC).
3. P1.21-07 Quantitative Assessment of OX40L and Its Association with Sensitivity to First-Line Pembrolizumab in Non-small-Cell Lung Cancer.
4. Vestas V90-3MW Wind Turbine Gearbox Health Assessment Using a Vibration-Based Condition Monitoring System.
5. Force transmissibility versus displacement transmissibility.
6. Force Magnitude Reconstruction Using the Force Transmissibility Concept.
7. 125P Benefit of immunotherapy in advanced NSCLC patients selected by KRAS mutations: A single institute retrospective analysis.
8. 218P Clinical characteristics and treatment outcomes in lung cancer patients with FGFR genes alterations.
9. 124P KRAS mutated (mt) non-small cell lung cancer (NSCLC) and response to antiPD-1/PD-L1 regarding co-mutational status and assessment of KRAS mutation on plasma or tissue biopsy.
10. 52P Genetic and clinical profiling of a cohort of extended small cell lung carcinoma.
11. 6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway.
12. Identification of fatigue damage evolution in 316L stainless steel using acoustic emission and digital image correlation
13. 1691P Thromboembolic disease and immunotherapy in lung cancer.
14. 1117P Mutational landscape of large cell neuroendocrine lung carcinoma: Molecular characterization using next generation sequencing.
15. 112P Immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in cancer patients receiving immunotherapy agents.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.